@article{TAU21986,
author = {Kyoung-Hwa Lee and Ja Hyeon Ku},
title = {Targeting splicing factors as molecular non-muscle invasive bladder cancer predictors},
journal = {Translational Andrology and Urology},
volume = {7},
number = {Suppl 6},
year = {2018},
keywords = {},
abstract = {Bladder cancer is the fourth most common cancer in men, with an estimated diagnosis of 60,490 new cases and 12,240 deaths in the United States in 2017 (1). Nearly 75% of bladder cancer patients are diagnosed with non-muscle invasive bladder cancer (NMIBC), which consists of stages Ta, T1, and carcinoma in situ (CIS). NMIBC is rarely lethal, but 50–70% of patients experience disease recurrence and 10–30% of patients’ progress to life-threatening muscle-invasive bladder cancer (MIBC) (2).},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/21986}
}